Patient-reported outcomes from a randomized open-label phase 3 trial comparing burosumab versus conventional therapy in children with X-linked hypophosphatemia: results from the 24-week treatment extension period

Padidela, R (author)

Whyte, MP (author)

Glorieux, FH (author)

show more...

Munns, CF (author)

Ward, LM (author)

Nilsson, O (author)

Portale, AA (author)

Simmons, JH (author)

Namba, N (author)

Cheong, HI (author)

Pitukcheewanont, P (author)

Sochett, E (author)

Hogler, W (author)

Muroya, K (author)

Gottesman, GS (author)

Biggin, A (author)

Perwad, F (author)

Williams, A (author)

Nixon, A (author)

Sun, W (author)

Chen, A (author)

Skrinar, A (author)

Imel, EA (author)

show less...

2022

2022

English.

In: HORMONE RESEARCH IN PAEDIATRICS. - 1663-2818. ; 95:SUPPL 2, s. 29-30

Related links:

http://kipublication...

• Conference paper (other academic/artistic)